← Back
$WVE All transactions

Wave Life Sciences Ltd.

A

$ Value

$0

Shares

273,750

Price

$0

Filed

Feb 11

Insider

Name

Moran Kyle

Title

Chief Financial Officer

CIK

0001657765

Roles

Officer

Transaction Details

Transaction Date

2026-02-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

273,750

Footnotes

Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030. | Includes 1,983 ordinary shares acquired on January 14, 2026, under the issuer's 2019 Employee Share Purchase Plan. | On February 9, 2026, the reporting person sold 3,588 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations. | The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030.

Filing Info

Accession No.

0001193125-26-047323

Form Type

4

Issuer CIK

0001631574

Moran Kyle's History

Date Ticker Type Value
2026-02-09 WVE $48K
2026-02-05 WVE A $0
2026-02-05 WVE A $0
2025-12-09 WVE M $294K
2025-12-09 WVE $729
2025-12-09 WVE M $524K
2025-12-09 WVE $1.0M
2025-12-09 WVE A $0
2025-12-09 WVE A $0
2025-12-08 WVE M $170K

Other Insiders at WVE (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $54.6M 2026-03-30
Vargeese Chandra
See Remarks
$43K 2026-02-09
Francis Chris
See Remarks
$525K 2026-02-26
BOLNO PAUL
President and CEO
$141K 2026-02-09
Moran Kyle
Chief Financial Officer
$48K 2026-02-09
TAKANASHI KEN 2026-03-23